The worldwide oversupply of steel is generating losses for steel producer ArceloMittal, and cutbacks for U.S. Steel. As a result of the glut in steel, prices plunged to 2008 recession levels. Steel products companies obviously use it as a major input, so they benefit from low steel prices. Their products are used in construction and manufacturing, which are on an upswing - as a result of the growing economy. Therefore, steel product companies stand to reap substantial benefits. Here are some of the best steel companies TheStreet Quant Ratings says you should consider looking at. Number 4 is Commercial Metals. With a 'B' rating, the company's strengths can be seen in its compelling growth in net income and notable return on equity. 3rd is, Steel Dynamics. This rating is also a 'B.' Steel Dynamics thrives in its solid stock price performance and good revenue growth. Number 2 is Nucor Corporation. This too is a 'B' rating. The company flourishes in its cash flow from operations and increase in net income. Number 1 is Reliance Steel & Aluminum. With a 'B+' rating, the company's strengths can be seen in its good revenue growth and increase in net income. TheStreet Ratings are algorithmic stock picks based on 32 major data points. S&P 500 stocks rated 'buy' yielded a 16-and-a-half-percent return in 2014, beating the S&P 500 Total Return Index by more than 300 basis points. For the full reports on these stocks, you can check out TheStreet.com/QuantRatings.
More from Video
Amid the Selling, Here's the Big Question Now
How quickly do we find support, is what we'll want to know now, as the correction is occurring while economic optimism builds.
One Tweet Pulls the Rug Out From Under the Indexes
Despite the president's promise of no stimulus until after Nov. 3, there are no signs yet that this is the sort of correlated selling that leads to a deep correction.
A Technical Look at the New Dow Jones Industrial Average
Salesforce, Amgen and Honeywell will give a lift to the DJIA going forward.
Conagra Brands Looks Tastier After Its Upgrade to Buy
CAG has hung onto the bulk of its recent gains, and could rise to the $50 area, according to the charts and indicators.
Biogen Bulls Get a Lift From Quant Upgrade and Strengthening Charts
Breaking down an approach to the long side of this biotech stock.
Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation.
If you have questions, please contact us here.